Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
for Advanced Solid Tumor
Sites in Houston +7 more locations
Sponsor: MOMA Therapeutics
Sex: All·Age: 18+
Code: NCT06974110·Phase 1·Recruiting·Listed May 2025